| UniProt ID | OPRX_HUMAN | |
|---|---|---|
| UniProt AC | P41146 | |
| Protein Name | Nociceptin receptor | |
| Gene Name | OPRL1 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 370 | |
| Subcellular Localization |
Cell membrane Multi-pass membrane protein. Cytoplasmic vesicle. Ligand binding leads to receptor internalization into cytoplasmic vesicles, decreasing the amount of available receptor at the cell surface. Internalization requires phosphorylation at |
|
| Protein Description | G-protein coupled opioid receptor that functions as receptor for the endogenous neuropeptide nociceptin. Ligand binding causes a conformation change that triggers signaling via guanine nucleotide-binding proteins (G proteins) and modulates the activity of down-stream effectors. Signaling via G proteins mediates inhibition of adenylate cyclase activity and calcium channel activity. Arrestins modulate signaling via G proteins and mediate the activation of alternative signaling pathways that lead to the activation of MAP kinases. Plays a role in modulating nociception and the perception of pain. Plays a role in the regulation of locomotor activity by the neuropeptide nociceptin.. | |
| Protein Sequence | MEPLFPAPFWEVIYGSHLQGNLSLLSPNHSLLPPHLLLNASHGAFLPLGLKVTIVGLYLAVCVGGLLGNCLVMYVILRHTKMKTATNIYIFNLALADTLVLLTLPFQGTDILLGFWPFGNALCKTVIAIDYYNMFTSTFTLTAMSVDRYVAICHPIRALDVRTSSKAQAVNVAIWALASVVGVPVAIMGSAQVEDEEIECLVEIPTPQDYWGPVFAICIFLFSFIVPVLVISVCYSLMIRRLRGVRLLSGSREKDRNLRRITRLVLVVVAVFVGCWTPVQVFVLAQGLGVQPSSETAVAILRFCTALGYVNSCLNPILYAFLDENFKACFRKFCCASALRRDVQVSDRVRSIAKDVALACKTSETVPRPA | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 21 | N-linked_Glycosylation | YGSHLQGNLSLLSPN HCCCCCCCCCCCCCC | 17.31 | UniProtKB CARBOHYD | |
| 28 | N-linked_Glycosylation | NLSLLSPNHSLLPPH CCCCCCCCCCCCCHH | 33.72 | UniProtKB CARBOHYD | |
| 39 | N-linked_Glycosylation | LPPHLLLNASHGAFL CCHHHHHHCCCCCCC | 39.09 | UniProtKB CARBOHYD | |
| 164 | Phosphorylation | RALDVRTSSKAQAVN HHHCCCCCCHHHHHH | 21.19 | 24719451 | |
| 165 | Phosphorylation | ALDVRTSSKAQAVNV HHCCCCCCHHHHHHH | 31.25 | 24719451 | |
| 334 | S-palmitoylation | KACFRKFCCASALRR HHHHHHHHHHHHHHH | 1.81 | - | |
| 346 | Phosphorylation | LRRDVQVSDRVRSIA HHHCCCHHHHHHHHH | 11.56 | - | |
| 351 | Phosphorylation | QVSDRVRSIAKDVAL CHHHHHHHHHHHHHH | 24.84 | - | |
| 362 | Phosphorylation | DVALACKTSETVPRP HHHHHCCCCCCCCCC | 31.51 | 25072903 | |
| 363 | Phosphorylation | VALACKTSETVPRPA HHHHCCCCCCCCCCC | 19.43 | 22596163 | |
| 365 | Phosphorylation | LACKTSETVPRPA-- HHCCCCCCCCCCC-- | 35.26 | 25072903 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
| 346 | S | Phosphorylation | Kinase | GRK2 | P25098 | PSP |
| 346 | S | Phosphorylation | Kinase | GRK3 | P35626 | PSP |
| 351 | S | Phosphorylation | Kinase | GRK2 | P25098 | PSP |
| 351 | S | Phosphorylation | Kinase | GRK3 | P35626 | PSP |
| 362 | T | Phosphorylation | Kinase | GRK2 | P25098 | PSP |
| 362 | T | Phosphorylation | Kinase | GRK3 | P35626 | PSP |
| 363 | S | Phosphorylation | Kinase | GRK2 | P25098 | PSP |
| 363 | S | Phosphorylation | Kinase | GRK3 | P35626 | PSP |
| Modified Location | Modified Residue | Modification | Function | Reference |
|---|---|---|---|---|
| 363 | S | Phosphorylation |
| 23086955 |
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of OPRX_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| PNOC_HUMAN | PNOC | physical | 10692489 | |
| PNOC_HUMAN | PNOC | physical | 11097863 | |
| GASP1_HUMAN | GPRASP1 | physical | 15086532 |
| Kegg Drug | ||||||
|---|---|---|---|---|---|---|
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...